(Q33147811)

English

A postmarketing, open-label study to evaluate the tolerability and effectiveness of replacing standard-formulation doxazosin with doxazosin in the gastrointestinal therapeutic system formulation in adult patients with hypertension.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12075946%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A postmarketing, open-label study to evaluate the tolerability and effectiveness of replacing standard-formulation doxazosin with doxazosin in the gastrointestinal therapeutic system formulation in adult patients with hypertension (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12075946%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Rodrigo Jiménez-García

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12075946%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Jesús Esteban-Hernández

0 references

Angel Gil de Miguel

6

object named as

Angel Gil de Miguel

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12075946%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

Maria Anegón

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12075946%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Jesus Esteban

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12075946%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Veronica Sanz de Burgoa

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12075946%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Javier Martínez

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12075946%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12075946%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12075946%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12075946%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12075946%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

786-797

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12075946%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985152-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind trial of the efficacy and tolerability of doxazosin in the gastrointestinal therapeutic system, doxazosin standard, and placebo in patients with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985152-9

7 January 2021

based on heuristic

inferred from DOI database lookup

1993 guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Sub-Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985152-9

7 January 2021

based on heuristic

inferred from DOI database lookup

British Hypertension Society guidelines for hypertension management 1999: summary

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985152-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985152-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha-blocker therapy of hypertension. An unfulfilled promise

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985152-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985152-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Doxazosin: a study in a cohort of patients with hypertension in general practice--an interim report.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985152-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary results of the Norwegian doxazosin postmarketing surveillance study: A twelveweek experience

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985152-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of doxazosin in the gastrointestinal therapeutic system formulation versus doxazosin standard and placebo in mild-to-moderate hypertension. Doxazosin Investigators' Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985152-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985152-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Doxazosin GITS compared with doxazosin standard and placebo in patients with mild hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985152-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(02)85152-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12075946%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12075946%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33147811&oldid=1537622550"